Steroid avoidance or withdrawal in renal transplantation

Transplantation

Volumn 91, Issue 5, 2011, Pages

  Knight, Simon R ^a,b   Morris, Peter J ^a  

^a ROYAL COLLEGE OF SURGEONS OF ENGLAND   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; DRUG WITHDRAWAL; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LETTER; PRIORITY JOURNAL; RISK ASSESSMENT;

GRAFT REJECTION; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; RISK FACTORS; STEROIDS; TIME FACTORS; WITHHOLDING TREATMENT;

EID: 79952170014     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318208e6d9     Document Type: Letter

References (4)

1. Pascual J, Galeano C, Royuela A, et al. A systematic review on steroid withdrawal between 3 and 6 months after kidney transplantation. Transplantation 2010; 90: 343.
2. Knight SR, Morris PJ. Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis. Transplantation 2010; 89: 1.
3. Webster AC, Woodroffe RC, Taylor RS, et al. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: Meta-analysis and meta-regression of randomised trial data. BMJ 2005; 331: 810.
4. Sprangers B, Vanrenterghem Y. Steroid avoidance or withdrawal after kidney transplantation: A balancing act. Transplantation 2010; 90: 350.